SCHEMBL7112293

SCHEMBL7112293

O=C(CC1CC2CCC1C2)NCC(O)(CCc1ccccc1)c1nc2ccccc2o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.44
ALDH1A1 P00352 4/20 0.41
MAPT P10636 3/20 0.39
RAB9A P51151 2/20 0.39
HTT P42858 2/20 0.39
LMNA P02545 3/20 0.39
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
P2RX7 Q99572 1/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
EPHX2 P34913 1/20 0.34
FAAH O00519 1/20 0.34
CES1 P23141 1/20 0.34
DAGLA Q9Y4D2 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TSHR P16473 1/20 0.34
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049306 0.80 DAGLA (0.44) HPGDALDH1A1MAPTRAB9AHTT
SCHEMBL7045443 0.79 MEN1 (0.45) HPGDALDH1A1MAPTRAB9ALMNA
SCHEMBL6464160 0.77 LMNA (0.39) MAPTRAB9AHTTLMNAMEN1
SCHEMBL6472489 0.76 FAAH (0.36) HPGDALDH1A1MAPTRAB9ALMNA
SCHEMBL7042898 0.75 ALDH1A1 (0.49) HPGDALDH1A1FAAHCES1DAGLA
SCHEMBL7044868 0.74 LMNA (0.37) MAPTRAB9AHTTLMNAMEN1
SCHEMBL7044969 0.74 HPGD (0.43) HPGDALDH1A1MAPTLMNAMEN1
Hydrochloric Acid SCHEMBL6465937 0.74 FAAH (0.35) ALDH1A1MAPTRAB9ALMNAMEN1
SCHEMBL6467037 0.73 FAAH (0.36) HPGDALDH1A1MAPTRAB9ALMNA
SCHEMBL6466282 0.73 LMNA (0.39) MAPTRAB9AHTTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030232864-A1 Novel Compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2003-12-18 US disclosed
US-6576630-B1 Alkanoyl substituted benzooxazoles or naphthooxazoles AXYS PHARMACEUTICALS, INC. 2003-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232864-A1 Novel Compounds and compositions as protease inhibitors SERPINB1, CTRL, CTSZ HPGD 536/4885ALDH1A1 3027/4885MAPT 2414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.